Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 228,444 | 204,810 | 217,775 | 148,211 | 98,353 |
| Cost of Goods | 39,138 | 32,221 | 37,811 | 31,391 | 23,395 |
| Gross Profit | 189,306 | 172,589 | 179,964 | 116,820 | 74,958 |
| Operating Expenses | 34,903 | 17,430 | 27,240 | 26,022 | 44,108 |
| Operating Income | 154,541 | 155,380 | 153,535 | 91,189 | 31,245 |
| Interest Expense | 7,022 | 7,685 | 7,649 | 7,904 | 8,806 |
| Other Income | -2,830 | 3,324 | -3 | 5,889 | -7,598 |
| Pre-tax Income | 144,689 | 151,019 | 145,883 | 89,174 | 14,841 |
| Income Tax | 17,578 | 18,842 | 11,386 | 13,709 | 369 |
| Net Income Continuous | 127,111 | 132,177 | 134,497 | 75,465 | 25,209 |
| Minority Interests | 71,281 | 78,215 | 85,354 | 52,363 | -13,924 |
| Net Income | $55,830 | $53,962 | $49,143 | $23,102 | $25,209 |
| EPS Basic Total Ops | 0.45 | 0.46 | 0.44 | 0.24 | 0.60 |
| EPS Basic Continuous Ops | 0.99 | 1.12 | 1.20 | 0.78 | 0.62 |
| EPS Diluted Total Ops | 0.44 | 0.44 | 0.44 | 0.24 | 0.13 |
| EPS Diluted Continuous Ops | -0.67 | 0.51 | 1.20 | 0.78 | 0.22 |
| EBITDA(a) | $164,302 | $164,058 | $164,365 | $98,140 | $37,699 |